Insider tradingForm 4
ROCKET PHARMACEUTICALS, INC. (RCKT) Insider Trading
7 open-market trades reported since Aug 13, 2026: 0 purchases worth $0 and 7 sales worth $432K.
By insider
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Martin Wilson | General Counsel | 0 | $0 | 3 | $270K |
| Gaurav Shah | CEO | 0 | $0 | 2 | $17K |
| Christopher James Stevens | COO | 0 | $0 | 1 | $128K |
| Sarbani Chaudhuri | See Remarks | 0 | $0 | 1 | $16K |
All trades
| Filed | Insider | Type | Value | 3 mo. after |
|---|---|---|---|---|
| Sep 15 | Martin WilsonGeneral Counsel | ▼ SELL | $256K | |
| Aug 20 | Gaurav ShahCEO | ▼ SELL | $8K | |
| Aug 20 | Martin WilsonGeneral Counsel | ▼ SELL | $2K | |
| Aug 17 | Martin WilsonGeneral Counsel | ▼ SELL | $12K | |
| Aug 17 | Gaurav ShahCEO | ▼ SELL | $10K | |
| Aug 13 | Christopher James StevensCOO | ▼ SELL | $128K | |
| Aug 13 | Sarbani ChaudhuriSee Remarks | ▼ SELL | $16K |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings